NFE2L2 and multiple sclerosis: Accumulating evidence on AD, PD, Huntington’s disease (HD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) have demonstrated that the loss of Nrf2 exacerbates neurodegenerative symptoms [83].